Your browser doesn't support javascript.
loading
gastric mucosal protective effects of pentoxifylline in the rat
Journal of the Egyptian Society of Toxicology. 2004; 30: 29-34
in English | IMEMR | ID: emr-66680
ABSTRACT
The effects of pentoxifylline [PTX], a non-specific phosphodiesterase inhibitor were examined in rat models of gastric mucosal injury. Gastric mucosal damage was evoked in pylorus-ligated rats by subcutaneous [s.c.] administration of 20 mg/kg indomethacin together with oral administration of 2m 0.15 N HCI, by oral administration of acidified acetylsalicylic acid [200 mg/kg in 2 ml 0.15 N HCI] or by oral administration of l ml of 50% ethanol. The results showed that PTX [36 or 72 mg/kg, i. p.] given prior to indomethacin, acidified acetylsalicylic acid or 50% ethanol prevented the development of gastric mucosal damage by the ulcerogenic agents in a dose-dependent manner. In addition, PTX [36 or 72 mg/kg, i. p.] given to pylorus-ligated rats decreased gastric acid secretion. It is concluded that, PTX, when given at doses comparable to those used in man for treatment of circulatory disorders displayed anti-ulcerogenic activity in the rat in vivo
Subject(s)
Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Phosphodiesterase Inhibitors / Rats / Protective Agents / Models, Animal / Gastric Mucosa / Histology Limits: Animals Language: English Journal: J. Egypt. Soc. Toxicol. Year: 2004

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Phosphodiesterase Inhibitors / Rats / Protective Agents / Models, Animal / Gastric Mucosa / Histology Limits: Animals Language: English Journal: J. Egypt. Soc. Toxicol. Year: 2004